Semaglutide after 60

What the trials show for older adults

Older adults were well represented in some semaglutide research and thin in others. In the weight-loss trials behind the Wegovy injection, about 9% of participants were 65 to 75 and 1% were older. The large SELECT heart trial had many more: roughly 30% were 65 to 75 and 8% were over 75.

Across these studies, the label reports no overall difference in effectiveness between people 65 and older and younger adults. That is reassuring, but it is not the same as saying side effects land the same way. Older bodies have less reserve when nausea, poor intake or dehydration hit.

The fracture finding after 75

In SELECT, participants aged 75 and older who took Wegovy had more hip and pelvic fractures than those on placebo, and more serious adverse reactions overall. The label reports this without a definite explanation. Rapid weight loss, loss of muscle and bone, dizziness and falls are all plausible contributors.

This does not rule out treatment. It does mean bone health and fall risk belong in the conversation before you start, especially if you have osteoporosis, a prior fracture or balance problems.

Protecting muscle while you lose fat

Any meaningful weight loss includes some lean tissue, not just fat. After 60, when muscle is already harder to keep, that matters for strength, balance and independence. Eating much less because your appetite is muted can make it worse.

Your clinician will usually pair semaglutide with a plan to hold on to muscle, and may move dose increases more slowly if your intake drops too far.

• Resistance exercise two or more days a week, adapted to your joints and fitness.
• Protein at each meal, since smaller portions make it easy to fall short.
• Tracking strength and function, not just the scale.
• A bone density scan if you have not had one and your risk is raised.

Your medication list matters more

By your 60s you may take several medicines, and semaglutide interacts with how some of them behave. The label notes that slower stomach emptying can affect the absorption of oral medicines, so drugs that need careful dosing deserve monitoring.

Low blood sugar becomes a real risk if you take insulin or a sulfonylurea such as glipizide, and those doses may need to come down. If you take a diuretic or have reduced kidney function, the dehydration that can follow vomiting or diarrhea is more likely to strain the kidneys. Blood pressure medicines sometimes need adjusting as weight falls.

Tell any surgeon or endoscopy team that you take semaglutide. The label warns of a risk of inhaling stomach contents under anesthesia or deep sedation, and you may get special instructions before a procedure.

Hydration and side effects hit harder

Nausea, vomiting, diarrhea and constipation are the most common semaglutide side effects at any age. After 60, thirst signals are often weaker, and a few days of poor intake can tip into dehydration faster, bringing dizziness, falls and kidney strain.

A slower dose-escalation schedule, small frequent meals and a daily fluid goal are simple ways to lower that risk. Tell your clinician early if you cannot keep fluids down, feel lightheaded when you stand or notice you are passing much less urine. Severe stomach pain that spreads to the back, or pain in the upper right abdomen with fever or yellowing skin, needs urgent care because pancreatitis and gallbladder disease are listed warnings.

Who should not take it

• Anyone with a personal or family history of medullary thyroid carcinoma (MTC) or with MEN 2. Semaglutide carries a boxed warning about thyroid C-cell tumors seen in rodents; whether it causes them in people is unknown.
• People with a past episode of pancreatitis, unless carefully reviewed.
• People with severe stomach-emptying problems.
• Anyone already using another GLP-1 or tirzepatide product.

How HealifyMD adapts the plan

We look at your whole picture rather than age or BMI alone: heart and kidney health, bone and fall risk, your medicines and what you want to be able to do. Baseline labs help, and our comprehensive lab panel is $199.

Compounded semaglutide is from $299/month, or $550 for 2 months ($275/month), confirmed at the eligibility review. It is not FDA-approved, has not been reviewed by the FDA for safety, effectiveness or quality and is not equivalent to Wegovy. If you have coverage for a branded GLP-1, our weight loss membership is from $75/month.